Ozempic and Wegovy show potential to reduce mental health and substance abuse risks in new analysis

A new analysis suggests that diabetes and weight loss drugs, Ozempic and Wegovy, may lower the risk of substance abuse and cognitive issues. The study found a modest reduction in risks for various mental health disorders, including suicidal thoughts and dementia. The research, based on over 1.2 million medical records, indicates that these drugs could help with impulse control and addiction. However, experts caution that the findings are observational and require further clinical testing to confirm their validity. While the drugs show potential benefits, they also have known side effects, such as nausea and vomiting. The study's limitations include its focus on veterans, which may not represent the general population.